ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

Boundary; Opponents Of CMS Policy Step Up The Fight.

November 9, 2007

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

NIH Establishes Women’s Health Office, Responds To Criticism

September 14, 1990

Utah, NIEHS Report Finding BRACA1 Gene For Familial Breast, Ovarian Cancer

September 23, 1994

John & Florence Antione To Leave NCI for Jobs At Loma Linda Univ.

June 21, 1991

DCBD Board Okays Concept for Animal Holding Recompetition

December 5, 1986